Is Zura Bio Limited (94E.F) a Buy, Sell, or Hold?
FSX : 94E.F
Zura Bio Limited
$4.56 EUR
-$0.02 (-0.44%)
- Volume
- 151
- Average Volume
- 2
- Market Capitalization
- $433.19M
- P/E Ratio
- -4.80
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $6.00
- Year Low
- $1.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.33
Company Overview
FSX
Sandeep C. Kulkarni
Biotechnology
Healthcare
94E.F
40
US
EUR
Liquidity Metrics
0.00
19.33
19.33
19.21
0.00
Sales & Valuation
-$
0.00
2.71
-6.83
-0.65
Profitability
-$1.06
-$99.36M
0.00%
0.00%
-54.60%
-32.99%
P/E Metrics
-4.80
0.10
0.10
Analyst Price Target & Rating
2/5
8 Analysts
%
Financial Health Scores
15.82
2/9
$214.44M
$227.78M
$11.7M
-$79.92M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Marlyn Mathew | VP of Finance & Accounting and Principal Financial & Accounting Officer |
| Gary Whale | Chief Technology Officer |
| Muzammil Mustufa | Chief Business Officer |
| Theresa Lowry | Chief Human Resources Officer |
| Sandeep Chidambar Kulkarni | Co-Founder, CEO & Director |
| Kimberly Ann Davis | Chief Operating Officer, Chief Legal Officer & Corporate Secretary |
| Kiran Nistala MBBS | Chief Medical Officer & Head of Development |
Poll Results
No votes yet today — be the first to share your view!
About Zura Bio Limited (FSX:94E.F) Stock
Zura Bio Limited, a biotechnology firm in the clinical stage, is focused on creating and advancing novel therapeutic solutions for immune-related and inflammatory conditions. The company's portfolio includes ZB-168, an anti-IL7Rα inhibitor developed to modulate diseases influenced by the IL7 and TSLP biological pathways. Additionally, they are progressing with Torudokimab, a monoclonal antibody specifically designed to neutralize IL33, which is presently in Phase 2 clinical trials. Zura Bio Limited operates out of San Diego, California. ...
Frequently Asked Questions
-
What is the current Zura Bio Limited (94E.F) stock price?
-
Zura Bio Limited(FSX:94E.F) stock price is $4.56 in the last trading session. During the trading session, 94E.F stock reached the peak price of $6 while $1.18 was the lowest point it dropped to. The percentage change in 94E.F stock occurred in the recent session was --0.44% while the dollar amount for the price change in 94E.F stock was -$0.02.
-
94E.F's industry and sector of operation?
-
The FSX listed 94E.F is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of 94E.F?
-
Marlyn Mathew | VP of Finance & Accounting and Principal Financial & Accounting Officer
Gary Whale | Chief Technology Officer
Muzammil Mustufa | Chief Business Officer
Theresa Lowry | Chief Human Resources Officer
Sandeep Chidambar Kulkarni | Co-Founder, CEO & Director -
How many employees does 94E.F have?
-
Number of 94E.F employees currently stands at 40. 94E.F operates from 4225 Executive Square, Henderson, NV 92037, US.
-
Link for 94E.F official website?
-
Official Website of 94E.F is: https://zurabio.com
-
How do I contact 94E.F?
-
94E.F could be contacted at phone #858 247 0520 and can also be accessed through its website. 94E.F operates from 4225 Executive Square, Henderson, NV 92037, US.
-
How many shares of 94E.F are traded daily?
-
The average number of 94E.F shares traded daily for last 3 months was 2.
-
What is the market cap of 94E.F currently?
-
The market value of 94E.F currently stands at $433.19M with its latest stock price at $4.56